» Articles » PMID: 21659519

Role of Putative Second Transmembrane Region of Nox2 Protein in the Structural Stability and Electron Transfer of the Phagocytic NADPH Oxidase

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2011 Jun 11
PMID 21659519
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Flavocytochrome b(558) (cytb) of phagocytes is a heterodimeric integral membrane protein composed of two subunits, p22(phox) and gp91(phox). The latter subunit, also known as Nox2, has a cytosolic C-terminal "dehydrogenase domain" containing FAD/NADPH-binding sites. The N-terminal half of Nox2 contains six predicted transmembrane α-helices coordinating two hemes. We studied the role of the second transmembrane α-helix, which contains a "hot spot" for mutations found in rare X(+) and X(-) chronic granulomatous disease. By site-directed mutagenesis and transfection in X-CGD PLB-985 cells, we examined the functional and structural impact of seven missense mutations affecting five residues. P56L and C59F mutations drastically influence the level of Nox2 expression indicating that these residues are important for the structural stability of Nox2. A53D, R54G, R54M, and R54S mutations do not affect spectral properties of oxidized/reduced cytb, oxidase complex assembly, FAD binding, nor iodonitrotetrazolium (INT) reductase (diaphorase) activity but inhibit superoxide production. This suggests that Ala-53 and Arg-54 are essential in control of electron transfer from FAD. Surprisingly, the A57E mutation partially inhibits FAD binding, diaphorase activity, and oxidase assembly and affects the affinity of immunopurified A57E cytochrome b(558) for p67(phox). By competition experiments, we demonstrated that the second transmembrane helix impacts on the function of the first intracytosolic B-loop in the control of diaphorase activity of Nox2. Finally, by comparing INT reductase activity of immunopurified mutated and wild type cytb under aerobiosis versus anaerobiosis, we showed that INT reduction reflects the electron transfer from NADPH to FAD only in the absence of superoxide production.

Citing Articles

X-ray structure and enzymatic study of a bacterial NADPH oxidase highlight the activation mechanism of eukaryotic NOX.

Petit-Hartlein I, Vermot A, Thepaut M, Humm A, Dupeux F, Dupuy J Elife. 2024; 13.

PMID: 38640072 PMC: 11031084. DOI: 10.7554/eLife.93759.


CRISPR-gene-engineered CYBB knock-out PLB-985 cells, a useful model to study functional impact of X-linked chronic granulomatous disease mutations: application to the G412E X91+-CGD mutation.

Beaumel S, Verbrugge L, Fieschi F, Stasia M Clin Exp Immunol. 2023; 212(2):156-165.

PMID: 36827093 PMC: 10128165. DOI: 10.1093/cei/uxad028.


Variant Type X91 Chronic Granulomatous Disease: Clinical and Molecular Characterization in a Chinese Cohort.

Sun B, Zhu Z, Hui X, Sun J, Wang W, Ying W J Clin Immunol. 2022; 42(7):1564-1579.

PMID: 35796921 PMC: 9674757. DOI: 10.1007/s10875-022-01324-3.


Membrane Dynamics and Organization of the Phagocyte NADPH Oxidase in PLB-985 Cells.

Joly J, Hudik E, Lecart S, Roos D, Verkuijlen P, Wrona D Front Cell Dev Biol. 2020; 8:608600.

PMID: 33365312 PMC: 7751761. DOI: 10.3389/fcell.2020.608600.


Clinical, functional and genetic characterization of 16 patients suffering from chronic granulomatous disease variants - identification of 11 novel mutations in CYBB.

Mollin M, Beaumel S, Vigne B, Brault J, Roux-Buisson N, Rendu J Clin Exp Immunol. 2020; 203(2):247-266.

PMID: 32954498 PMC: 7806450. DOI: 10.1111/cei.13520.


References
1.
Yu L, Dinauer M . Mutagenesis of an arginine- and lysine-rich domain in the gp91(phox) subunit of the phagocyte NADPH-oxidase flavocytochrome b558. J Biol Chem. 1999; 274(15):10451-7. DOI: 10.1074/jbc.274.15.10451. View

2.
Li X, Fieschi F, Paclet M, Grunwald D, Campion Y, Gaudin P . Leu505 of Nox2 is crucial for optimal p67phox-dependent activation of the flavocytochrome b558 during phagocytic NADPH oxidase assembly. J Leukoc Biol. 2006; 81(1):238-49. DOI: 10.1189/jlb.0905541. View

3.
Jaquet V, Scapozza L, Clark R, Krause K, Lambeth J . Small-molecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets. Antioxid Redox Signal. 2009; 11(10):2535-52. DOI: 10.1089/ars.2009.2585. View

4.
Aliverti A, Piubelli L, Zanetti G, Lubberstedt T, Herrmann R, Curti B . The role of cysteine residues of spinach ferredoxin-NADP+ reductase As assessed by site-directed mutagenesis. Biochemistry. 1993; 32(25):6374-80. DOI: 10.1021/bi00076a010. View

5.
Kakinuma K, Kaneda M, Chiba T, Ohnishi T . Electron spin resonance studies on a flavoprotein in neutrophil plasma membranes. Redox potentials of the flavin and its participation in NADPH oxidase. J Biol Chem. 1986; 261(20):9426-32. View